Keymed Biosciences Inc.
2162
Ранг среди акций
#4889
Keymed Biosciences Inc., a biotechnology firm founded in 2016 in Chengdu, China... Keymed Biosciences Inc., a biotechnology firm founded in 2016 in Chengdu, China (formerly known as 2Health Biosciences, Inc.), specializes in the research and development of innovative biological treatments, primarily targeting autoimmune and oncology diseases. A cornerstone of their pipeline is CM310, their lead product candidate, which is currently being developed for the management of moderate to severe atopic dermatitis (AD), asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP), and chronic obstructive pulmonary disease (COPD). Complementing this, the company is also progressing CM326, a monoclonal antibody designed to inhibit thymic stromal lymphopoietin, for similar indications such as AD, CRSwNP, asthma, and COPD. In the realm of oncology, Keymed is developing CMG901 for solid tumors, particularly those affecting the stomach and gastroesophageal junction. Another significant candidate, CM313, is a humanized monoclonal antibody slated for the treatment of relapsed or refractory multiple myeloma, lymphoma, other blood cancers, and systemic lupus erythematosus. Their extensive portfolio further includes MIL95/CM312, a humanized monoclonal antibody targeting CD47; CM338, an antagonist antibody against mannose-binding lectin-associated serine protease-2; CM355, intended for relapsed or refractory non-Hodgkin's lymphoma; CM336, for multiple myeloma; CM350, for various solid tumors; and CM369, an anti-CC chemokine receptor 8 monoclonal antibody.
Цена акции
$10.08
Рыночная капитализация
$2.97B
Изменение (1 день)
-8.18%
Изменение (1 год)
25.74%
Страна
CN
Торговля Keymed Biosciences Inc. (2162)
Категория
Healthcare
Количество находящихся в обращении акций Keymed Biosciences Inc. (2162)
Количество акций в обращении на October 2026: 0
Согласно последним финансовым отчетам и цене акций Keymed Biosciences Inc., текущее количество акций в обращении составляет 0. На конец October 2026 у компании было 0 акций в обращении. Количество акций в обращении обычно зависит от сплитов и обратного выкупа акций.
История количества акций в обращении Keymed Biosciences Inc. (2162) с 2019 по 2026
Акции в обращении на конец каждого года
| Год | Акции в обращении | Изменить |
|---|---|---|
| 2025 | 273.98M | 4.59% |
| 2024 | 261.95M | 0.22% |
| 2023 | 261.37M | 0.09% |
| 2022 | 261.13M | 62.34% |
| 2021 | 160.85M | -25.51% |
| 2020 | 215.92M | -20.32% |
| 2019 | 271.00M | 0.00% |
Акции в обращении у аналогичных компаний или конкурентов
| Компания | Акции в обращении | Разница | Страна |
|---|---|---|---|
| 253.90M | - |
US
|
|
| 396.00M | - |
US
|
|
| 478.91M | - |
AU
|
|
| 62.19M | - |
NL
|
|
| - | - |
CH
|
